Literature DB >> 203506

Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon.

R L Gingerich, P E Lacy, R E Chance, M G Johnson.   

Abstract

The regional concentrations and in-vitro secretions of canine pancreatic polypeptide (cPP), insulin, and glucagon were studied. CPP is found predominantly in the uncinate process of the dog pancreas, whereas insulin and, more markedly, glucagon predominate in the body and tail of the pancreas. In-vitro secretion studies of pancreatic pieces indicate that dibutyryl cyclic AMP (dcAMP) alone can stimulate cPP release whereas glucose and arginine alone have no effect. Arginine, but not glucose, potentiates this stimulant effect of dcAMP. These studies suggest that the cAMP generating system may play a role in regulation of cPP secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203506     DOI: 10.2337/diab.27.2.96

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.

Authors:  P J Boyle; S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

2.  Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.

Authors:  C J Greenbaum; P J Havel; G J Taborsky; L J Klaff
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

4.  The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas.

Authors:  R Kleinman; R Gingerich; G Ohning; H Wong; K Olthoff; J Walsh; F C Brunicardi
Journal:  Int J Pancreatol       Date:  1995-08

5.  Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure.

Authors:  Ana Maria Arbelaez; William J Powers; Tom O Videen; Joseph L Price; Philip E Cryer
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

6.  Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

Authors:  S E Dagogo-Jack; S Craft; P E Cryer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Adaptation in brain glucose uptake following recurrent hypoglycemia.

Authors:  P J Boyle; R J Nagy; A M O'Connor; S F Kempers; R A Yeo; C Qualls
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Pancreatic polypeptide in acute pancreatitis and small-bowel infarction in dogs.

Authors:  T N Pappas; J G Yovos; E C Ellison; T M O'Dorisio; S Cataland; W G Pace; L C Carey
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

9.  Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus.

Authors:  Sajan Jiv Singh Nagpal; William R Bamlet; Yogish C Kudva; Suresh T Chari
Journal:  Pancreas       Date:  2018-07       Impact factor: 3.327

10.  Effects of amino acids on pancreatic polypeptide before and after vagotomy in the dog.

Authors:  A Inui; N Mizuno; M Oya; H Morioka; T Ogawa; M Ishida; S Baba
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.